Table 5

ā€ƒAdverse events in both treatments during follow up

EventMPCy
Urinary tract infections810
Respiratory46
Oropharyngeal candidiasis02
Herpes zoster02
Systemic hypertension10
Hyperglycaemia10
Pancreatitis10
Death13